Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trialMichael J. Pishvaian, Emanuel F. Petricoin, Lola Rahib et al.|The Lancet Oncology|2020Cited by 541
Metastatic Pancreatic Cancer: ASCO Guideline UpdateDavendra Sohal, Daniel A. Laheru, Erin B. Kennedy et al.|Journal of Clinical Oncology|2020Cited by 287
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinomaWeijing Sun, Kim M. Olthoff, Davendra Sohal et al.|Cancer|2011Cited by 97
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinomaDavendra Sohal, Weijing Sun, Kristine Mykulowycz et al.|Annals of Oncology|2013Cited by 89
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerVivek Nimgaonkar, Eric A. Collisson, Viswesh Krishna et al.|Cell Reports Medicine|2023Cited by 19